162 related articles for article (PubMed ID: 8878581)
1. In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
Chavanet P; Peyrard N; Pechinot A; Buisson M; Duong M; Neuwirth C; Kazmierczak A; Portier H
Antimicrob Agents Chemother; 1996 Sep; 40(9):2062-66. PubMed ID: 8878581
[TBL] [Abstract][Full Text] [Related]
2. In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
Chavanet P; Beloeil H; Pechinot A; Duigou F; Buisson JC; Duong M; Neuwirth C; Kazmierczak A; Portier H
Antimicrob Agents Chemother; 1995 Aug; 39(8):1736-43. PubMed ID: 7486911
[TBL] [Abstract][Full Text] [Related]
3. In-vivo activity and pharmacodynamics of cefotaxime in combination with vancomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
Chavanet P; Champliaud D; Pechinot A; Buisson M; Duong M; Neuwirth C; Kazmierczak A; Portier H
J Antimicrob Chemother; 1996 Oct; 38(4):655-70. PubMed ID: 8937960
[TBL] [Abstract][Full Text] [Related]
4. Experimental efficacy of combined ceftriaxone and amoxycillin on penicillin-resistant and broad-spectrum cephalosporin-resistant Streptococcus pneumoniae infection.
Chavanet P; Dalle F; Delisle P; Duong M; Pechinot A; Buisson M; D'Athis P; Portier H
J Antimicrob Chemother; 1998 Feb; 41(2):237-46. PubMed ID: 9533466
[TBL] [Abstract][Full Text] [Related]
5. In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.
Andes D; Craig WA
Antimicrob Agents Chemother; 1998 Sep; 42(9):2375-9. PubMed ID: 9736566
[TBL] [Abstract][Full Text] [Related]
6. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae.
Woodnutt G; Berry V
Antimicrob Agents Chemother; 1999 Jan; 43(1):35-40. PubMed ID: 9869562
[TBL] [Abstract][Full Text] [Related]
8. Effects of combination of benzylpenicillin and fosfomycin on penicillin-resistant Streptococcus pneumoniae.
Kikuchi K; Totsuka K; Shimizu K; Ishii T; Yoshida T; Orikasa Y
Microb Drug Resist; 1995; 1(2):185-9. PubMed ID: 9158754
[TBL] [Abstract][Full Text] [Related]
9. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
Bañón Arias R; García López M; Pinedo Sánchez A
J Chemother; 2001 Oct; 13(5):535-40. PubMed ID: 11760218
[TBL] [Abstract][Full Text] [Related]
10. Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains.
Azoulay-Dupuis E; Moine P; Bedos JP; Rieux V; Vallee E
Antimicrob Agents Chemother; 1996 Apr; 40(4):941-6. PubMed ID: 8849256
[TBL] [Abstract][Full Text] [Related]
11. Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.
Lister PD; Pong A; Chartrand SA; Sanders CC
Antimicrob Agents Chemother; 1997 Sep; 41(9):1926-32. PubMed ID: 9303386
[TBL] [Abstract][Full Text] [Related]
12. Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem.
Ponte C; Parra A; Nieto E; Soriano F
Antimicrob Agents Chemother; 1996 Dec; 40(12):2698-702. PubMed ID: 9124825
[TBL] [Abstract][Full Text] [Related]
13. In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media.
Cenjor C; Ponte C; Parra A; Nieto E; García-Calvo G; Giménez MJ; Aguilar L; Soriano F
Antimicrob Agents Chemother; 1998 Jun; 42(6):1361-4. PubMed ID: 9624476
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens.
Odenholt I; Cars O; Löwdin E
J Antimicrob Chemother; 2004 Dec; 54(6):1062-6. PubMed ID: 15563517
[TBL] [Abstract][Full Text] [Related]
15. Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics.
Abgueguen P; Azoulay-Dupuis E; Noel V; Moine P; Rieux V; Fantin B; Bedos JP
Antimicrob Agents Chemother; 2007 Jan; 51(1):208-14. PubMed ID: 17060515
[TBL] [Abstract][Full Text] [Related]
16. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
Gavaldà J; Capdevila JA; Almirante B; Otero J; Ruiz I; Laguarda M; Allende H; Crespo E; Pigrau C; Pahissa A
Antimicrob Agents Chemother; 1997 Apr; 41(4):795-801. PubMed ID: 9087492
[TBL] [Abstract][Full Text] [Related]
17. Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics.
Piroth L; Martin L; Coulon A; Lequeu C; Duong M; Buisson M; Portier H; Chavanet P
Antimicrob Agents Chemother; 1999 Oct; 43(10):2484-92. PubMed ID: 10508029
[TBL] [Abstract][Full Text] [Related]
18. Effect of antibiotic treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniae strains with different susceptibilities to amoxicillin.
Parra A; Ponte C; Cenjor C; Martínez-Marín C; Soriano F;
Antimicrob Agents Chemother; 2004 Mar; 48(3):860-6. PubMed ID: 14982776
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model.
Knudsen JD; Frimodt-Møller N; Espersen F
J Antimicrob Chemother; 1998 Apr; 41(4):451-9. PubMed ID: 9598776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
